Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Agios Pharmaceuticals Inc (NASDAQ:AGIO)

48.20
Delayed Data
As of May 26
 +0.74 / +1.56%
Today’s Change
35.84
Today|||52-Week Range
67.74
+15.50%
Year-to-Date
No recent news for Agios Pharmaceuticals Inc.

Today’s Trading

Previous close47.46
Today’s open47.53
Day’s range46.84 - 48.24
Volume492,347
Average volume (3 months)585,075
Market cap$2.3B
Dividend yield--
Data as of 3:59pm ET, 05/26/2017

Growth & Valuation

Earnings growth (last year)-60.95%
Earnings growth (this year)--
Earnings growth (next 5 years)--
Revenue growth (last year)+18.22%
P/E ratioNM
Price/Sales23.36
Price/Book5.59

Competitors

 Today’s
change
Today’s
% change
AXONAxovant Sciences Ltd+0.02+0.09%
LGNDLigand Pharmaceutica...-3.31-2.92%
PTLAPortola Pharmaceutic...-1.21-3.19%
CLVSClovis Oncology Inc-2.87-5.21%
Data as of 4:00pm ET, 05/26/2017

Financials

Next reporting dateAugust 10, 2017
EPS forecast (this quarter)-$1.57
Annual revenue (last year)$69.9M
Annual profit (last year)-$198.5M
Net profit margin-283.97%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
David Paul Schenkein
Chief Financial Officer
Andrew J. Hirsch
Corporate headquarters
Cambridge, Massachusetts

Forecasts